- STAT+: Glenmark to pay $29.6 million to settle price-fixing allegations in long-running battle with statesGlenmark Pharmaceuticals agreed to pay $29.6 million to settle price-fixing allegations in a long-running battle with dozens of states.STAT · 9d ago↗ source
- STAT+: In a major policy shift, Medicare proposes to ban vendors from providing remote monitoring servicesMedicare is proposing to ban vendors from providing remote patient monitoring services on behalf of doctors.STAT · 9d ago↗ source
- Radiopharma maker AdvanCell hauls in $315M for Pluvicto challengerAdvanCell raised a $315 million Series D to study a lead-based prostate cancer agent and shore up its US manufacturing of the radioactive treatment. The round marks one of the largest yet for a r…